AbbVie stock trades at EUR 240.60 with a USD 476.7 billion market cap
Published on 10/08/2026 at 19:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- AbbVie stock was at EUR 240.60 at Lang & Schwarz on October 8, 2026 at 7:46 p.m. CEST, down 1.33 percent from EUR 243.85.
- The NYSE quote was USD 269.80 at 1:56 p.m. ET, placing it 1.9 percent below the USD 274.94 52-week high.
- AbbVie had a USD 476.7 billion market capitalization and a P/E ratio of 76.02 on October 8, 2026.
- AbbVie is scheduled to report third-quarter 2026 results before the market opens on October 30, 2026.
AbbVie Inc. (ISIN US00287Y1091) was trading at EUR 240.60 at Lang & Schwarz on October 8, 2026 at 7:46 p.m. CEST, minus 1.33 percent versus the prior close of EUR 243.85. The move gives German-market investors a clear after-hours reading while the US listing remained open.
US quote and yearly range
On the NYSE, ABBV was trading at USD 269.80 at 1:56 p.m. ET on October 8, 2026. That price was 1.9 percent below the USD 274.94 52-week high and remained above the USD 190.75 52-week low.
The two quotations use different currencies and venues, so the euro price and the NYSE price describe separate market references. The Lang & Schwarz bid was EUR 240.30 and the ask was EUR 240.90 at 7:46 p.m. CEST.
Market value and valuation
AbbVie carried a market capitalization of USD 476.7 billion and a P/E ratio of 76.02 on October 8, 2026. The comparison is material because the valuation multiple is well above the ratios shown for the two pharmaceutical peers in the peer block below.
The next scheduled company event is third-quarter 2026 earnings. StockTitan reported on October 1, 2026 that AbbVie will announce results before the market opens on October 30, 2026.
Comparison with peers
AbbVie Inc.: minus 1.33 percent, P/E 76.02, market capitalization USD 476.7 billion
Amgen (NASDAQ, USD): minus 1.61 percent, P/E 25.26, market capitalization USD 219.4 billion
Gilead Sciences (NASDAQ, USD): minus 0.48 percent, P/E minus 54.75, market capitalization USD 181.2 billion
After-hours price and investor frame
AbbVie stock was trading at EUR 240.60 at Lang & Schwarz on October 8, 2026 at 7:46 p.m. CEST, versus the prior close of EUR 243.85. The euro quote, the USD 476.7 billion market capitalization and the 1.9 percent gap to the NYSE 52-week high give the market report three distinct reference points.
The further course of trading is shown by the continuously updated real-time quote of AbbVie stock.
AbbVie stock market snapshot
- Company: AbbVie Inc.
- ISIN: US00287Y1091
- Ticker: ABBV
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026 at 7:46 p.m. CEST: EUR 240.60
- Change versus prior close: minus 1.33 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 243.85
- Market capitalization: USD 476.7 billion (as of October 8, 2026)
- 52-week range: USD 190.75-274.94 (as of October 8, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
Market context: Market report S&P 500.
